Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Novo Nordisk says that Lars Rebien Sorensen will retire as chief executive officer and president by the end of 2016 and that Lars Fruergaard Jorgensen, who is currently executive vice president and head of corporate development, will succeed him.
More Novo Nordisk changes:
Jakob Riis, who is currently executive vice president and head of region China, Pacific & marketing, was named executive vice president and head of North America Operations. He succeeds Jesper Hoiland, who steps down from executive management and whose future role will be announced at a later date;
Maziar Doustdar, who is currently executive vice president and head of international operations, will have an expanded role that includes responsibilities for most regions, except North America;
Jerzy Gruhn, who is currently executive vice president and head of Europe, steps down from executive management and will continue as head of Europe, but as senior vice president;
Daiichi Sankyo hired Leigh Ann Errico as vp of human resources for its US administrative and commercial group;
Forma Therapeutics hired Karoline Shair as vice president, legal and chief intellectual property counsel;
Cellceutix hired Jane Harness as vice president, clinical sciences and portfolio management;
Caribou Biosciences hired Vonnie Estes as group leader;
Nuvo Pharmaceuticals named Mary-Jane Burkett as vice president and chief financial officer.